Google
TECX — TECTONIC THERAPEUTIC, INC. (Healthcare >> Biotechnology)
TECX FAQ
What is TECX's ROE?
TECTONIC THERAPEUTIC, INC. reports a Return on Equity (ROE) of -36.23%.
What is TECX's dividend yield?
TECTONIC THERAPEUTIC, INC. offers a dividend yield of 0.00%.
What is TECX's Deepscope Quality Score?
Deepscope rates TECX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TECX?
Deepscope's AI Timing Score for TECX is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TECX belong to?
TECTONIC THERAPEUTIC, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 29.13
Price
-0.13
(-0.45%)
Day Change
|
|
|---|
TECX, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 29.13 |
| PBV / Sector |
2.33 / 4.58
|
| Earning Per Share | -4.53 |
| PE / Sector |
N/A / 17.10
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
6.56 M
|
| Average 1W Daily Value |
3.49 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-05 09:12:10 |
| Symbol | TECX |
| Name | TECTONIC THERAPEUTIC, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 18.87 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 536.26 / 8,655.90 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 490 Arsenal Way, Watertown, MA, United States, 02472
Phone: 339 666 3320
Website: https://tectonictx.com
Employees: 60
Sector: Healthcare >> Biotechnology
Description: Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
